Pulmonology Medical News about Lung Transplant

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Adoptive T-Cell Therapy of a Lung Transplanted Patient with Severe CMV Disease and Resistance to Antiviral Therapy
American Journal of Transplantation, 05/22/09

Brestrich G et al. - The experimental data indicate that this could be the consequence of the late differentiated phenotype of the infused T cells and therefore their insufficient longevity in vivo. The report signifies the high therapeutic potential of adoptive immunotherapy in the treatment of SOT recipients when all other measures show no effect.

Exclusive Author Commentary
Gordon Brestrich, 05/25/09

The adoptive transfer of specific T-cell lines was examined as a new treatment strategy for SOT recipients suffering from severe CMV infections with resistance to antiviral therapy. The approach led to a significant improvement of the clinical symptomes, however this effect was only transient. The experimental data indicate that this could be the consequence of the late differentiated phenotype of the infused T cells and therefore their insufficient longevity in vivo. The report signifies the high therapeutic potential of adoptive immunotherapy in the treatment of SOT recipients when all other measures show no effect.

<< Previous
Priming of Alveolar Macrophages upon Instillation of...

Next >>
Effect of N-Acetylcysteine in Attenuating Ischemic Reperfusion...